This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $96.84 to $108.45 in the past one-month time frame.Investors interested in the Medical - Biomedical and Genetics industry may consider Akcea Therapeutics Inc AKCA, which has a Zacks Rank #1 (Strong Buy).